Description
NSI-189 is a benzylpiperazine-aminopyridine compound known for its interaction with neurogenic and neurotrophic pathways. It is structurally classified as a pyridine-based small molecule with a high degree of lipophilicity, contributing to its molecular stability and bioavailability.
This compound undergoes hepatic metabolism via oxidation and conjugation, with primary clearance occurring through renal and biliary excretion.